Inventor · disambiguated record
Linus Backert
Also filed as: BACKERT LINUS
12 granted patents·2 pending applications·0 citations·filing 2018–2023
86Inventor score
Files withIMMATICS BIOTECHNOLOGIES GMBH14
Top patents by PatentIndex Score
14 records- 0187US2023226162A1A*03 restricted peptides for use in immunotherapy against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 0286US11576955B2A*03 restricted peptides for use in immunotherapy against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Feb 14, 2023·0 cites·20 claims
- 0386US11554164B2A*03 restricted peptides for use in immunotherapy against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Jan 17, 2023·0 cites·20 claims
- 0481US12076379B2A*03 restricted peptides for use in immunotherapy against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Sep 3, 2024·0 cites·20 claims
- 0581US11246917B2A*03 restricted peptides for use in immunotherapy against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Feb 15, 2022·0 cites·20 claims
- 0681US10946081B2*03 restricted peptides for use in immunotherapy against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Mar 16, 2021·0 cites·20 claims
- 0779US11872270B2A*03 restricted peptides for use in immunotherapy against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Jan 16, 2024·0 cites·20 claims
- 0879US11833193B2A*03 restricted peptides for use in immunotherapy against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Dec 5, 2023·0 cites·20 claims
- 0979US11058755B2A*03 restricted peptides for use in immunotherapy against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Jul 13, 2021·0 cites·20 claims
- 1077US10869917B2A*03 restricted peptides for use in immunotherapy against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Dec 22, 2020·0 cites·20 claims
- 1176US10925947B2A*03 restricted peptides for use in immunotherapy against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Feb 23, 2021·0 cites·30 claims
- 1276US10828357B2A*03 restricted peptides for use in immunotherapy against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Nov 10, 2020·0 cites·20 claims
- 1357US2022283176A1Method for the absolute quantification of mhc moleculesIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Application pending·0 cites
- 1452US12480958B2Method for the characterization of peptide:MHC binding polypeptidesIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Nov 25, 2025·0 cites·22 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →